/Companies

Metly

2 known investors

Find your way into Metly

Sign up to see every warm intro you have to Metly

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Metly team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Metly is an AI-native pharma intelligence platform that aggregates internal and external data to search regulatory filings, clinical databases, and partnership signals, monitor competitors, and automatically update intelligence workflows. It serves pharma and biotech teams for competitive intelligence, business development, licensing, market access, and asset diligence, pairing its platform with therapeutic-area experts.

Investors · 2

Funding

SEC filings, press & company announcements
  • Undisclosed amountpre-seed roundJul 2025 · 3 sources
    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Metly do?
Metly is an AI-native pharma intelligence platform that aggregates internal and external data to search regulatory filings, clinical databases, and partnership signals, monitor competitors, and automatically update intelligence workflows. It serves pharma and biotech teams for competitive intelligence, business development, licensing, market access, and asset diligence, pairing its platform with therapeutic-area experts.
Who are Metly's investors?
Metly's investors include Dozen Investments, Encomenda VC.